CSMS# 16-000562 - END OF INCREASED SURVEILLANCE OF FDA-REGULATED PRODUCTS FROM TIANJIN, CHINA
U.S. Customs and Border Protection sent this bulletin at 07/06/2016 10:21 AM EDTYou are subscribed to Trade Policy Updates for U.S. Customs and Border Protection. This information has recently been updated, and is now available.
07/06/2016 09:40 AM EDT
Trade Policy Updates
FDA is issuing this communication as notification of the end of FDA’s increased surveillance of certain FDA-regulated products imported from the industrial center Binhai New Area in Tianjin, China, and Xiditou Township of Beichen District in Tianjin, China.
FDA has returned to routine surveillance of FDA-regulated products from this region.
Questions regarding this action by FDA can be directed to Division of Import Operations, 12420 Parklawn Drive, ELEM Room 3109, Rockville, MD 20857 telephone: (301) 796-0356.
FDA is issuing this communication as notification of the end of FDA’s increased surveillance of certain FDA-regulated products imported from the industrial center Binhai New Area in Tianjin, China, and Xiditou Township of Beichen District in Tianjin, China.
FDA has returned to routine surveillance of FDA-regulated products from this region.
Questions regarding this action by FDA can be directed to Division of Import Operations, 12420 Parklawn Drive, ELEM Room 3109, Rockville, MD 20857 telephone: (301) 796-0356.
Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com.
This service is provided to you at no charge by U.S. Customs and Border Protection.
Privacy Policy | GovDelivery is providing this information on behalf of U.S. Department of Homeland Security, and may not use the information for any other purposes.
 |
 |